Tilray (TLRY) to Release Earnings on Tuesday

Tilray (NASDAQ:TLRY) is scheduled to be posting its quarterly earnings results before the market opens on Tuesday, April 9th. Analysts expect Tilray to post earnings of ($0.04) per share for the quarter. Individual that are interested in participating in the company’s earnings conference call can do so using this link.

Tilray Price Performance

Shares of TLRY stock opened at $2.60 on Monday. The stock has a market cap of $1.93 billion, a price-to-earnings ratio of -1.17 and a beta of 2.36. The business’s fifty day moving average is $1.95 and its 200 day moving average is $1.98. Tilray has a twelve month low of $1.50 and a twelve month high of $3.40. The company has a quick ratio of 0.99, a current ratio of 1.63 and a debt-to-equity ratio of 0.11.

Insider Activity

In related news, CFO Carl A. Merton acquired 20,000 shares of the firm’s stock in a transaction dated Friday, January 12th. The shares were purchased at an average price of $1.87 per share, with a total value of $37,400.00. Following the completion of the purchase, the chief financial officer now directly owns 20,000 shares of the company’s stock, valued at $37,400. The purchase was disclosed in a document filed with the SEC, which can be accessed through the SEC website. In related news, CFO Carl A. Merton acquired 20,000 shares of the firm’s stock in a transaction dated Friday, January 12th. The shares were purchased at an average price of $1.87 per share, with a total value of $37,400.00. Following the completion of the purchase, the chief financial officer now directly owns 20,000 shares of the company’s stock, valued at $37,400. The purchase was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CEO Irwin D. Simon bought 53,700 shares of the business’s stock in a transaction that occurred on Friday, January 12th. The shares were acquired at an average price of $1.88 per share, with a total value of $100,956.00. Following the transaction, the chief executive officer now directly owns 2,033,058 shares of the company’s stock, valued at approximately $3,822,149.04. The disclosure for this purchase can be found here. Insiders have acquired a total of 96,300 shares of company stock valued at $183,210 over the last ninety days. 0.68% of the stock is currently owned by corporate insiders.

Institutional Trading of Tilray

Several institutional investors have recently made changes to their positions in the business. Mercer Global Advisors Inc. ADV grew its position in shares of Tilray by 10.0% during the third quarter. Mercer Global Advisors Inc. ADV now owns 28,072 shares of the company’s stock worth $77,000 after purchasing an additional 2,550 shares in the last quarter. Rhumbline Advisers grew its position in shares of Tilray by 20.4% during the second quarter. Rhumbline Advisers now owns 15,464 shares of the company’s stock worth $48,000 after purchasing an additional 2,623 shares in the last quarter. CreativeOne Wealth LLC grew its position in shares of Tilray by 8.0% during the third quarter. CreativeOne Wealth LLC now owns 40,591 shares of the company’s stock worth $112,000 after purchasing an additional 2,994 shares in the last quarter. State of Wyoming grew its position in shares of Tilray by 17.0% during the fourth quarter. State of Wyoming now owns 24,561 shares of the company’s stock worth $66,000 after purchasing an additional 3,564 shares in the last quarter. Finally, Mariner LLC grew its position in shares of Tilray by 11.1% during the fourth quarter. Mariner LLC now owns 49,469 shares of the company’s stock worth $133,000 after purchasing an additional 4,945 shares in the last quarter. Hedge funds and other institutional investors own 9.35% of the company’s stock.

Wall Street Analysts Forecast Growth

Separately, Alliance Global Partners upped their price target on Tilray from $2.25 to $2.75 and gave the stock a “neutral” rating in a research note on Friday.

About Tilray

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Nanaimo, Canada.